GenSight Biologics announced the appointment of Magali Taiel, MD, as Chief Medical Officer, effective immediately. Dr. Taiel replaces Barrett Katz, MD, who resigned to pursue other career opportunities. She has been Vice President of Clinical Development since September 2018. Dr. Katz will remain a consultant to the Company. Dr. Taiel, a medical doctor board-certified in Ophthalmology, brings extensive years of experience from both academic medicine and the pharmaceutical industry. She will oversee clinical development and operations, medical affairs and scientific communication at GenSight Biologics. She will be part of the Executive Committee and will report directly to CEO Bernard Gilly.